Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 2

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 2
---
ation Amendment Proposal, the “M&A Amendment Proposals”); and

(iv) Proposal 5 —
A proposal to approve by ordinary resolution the adjournment of the Meeting to a later date or dates, if necessary, to permit further
solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of
any of the foregoing proposals (the “Adjournment Proposal”).

Approval of the M&A Amendment
Proposals are each conditioned on one another. This means that unless those three proposals are approved by the shareholders, none of
the three M&A Amendment Proposals will take effect.

<div align='center'>2</div>

Each of the M&A Amendment
Proposals, the Auditor Ratification Proposal and the Adjournment Proposal is more fully described in the accompanying proxy statement.

Only holders of record of
our class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares” or “Class A ordinary shares”) and our class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”
or “Class B ordinary shares”, and together with the Class A Ordinary Shares, the “Ordinary Shares”)
at the close of business on November 3, 2025 are entitled to notice of the Meeting and to vote at the Meeting and any adjournments
or postponements of the Meeting.

Our Board has approved the
Extension Amendment Proposal, the Auditor Ratification Proposal, the Liquidation Amendment Proposal, the Redemption Limitation Amendment
Proposal, and the Adjournment Proposal, and recommends that shareholders vote in favor of each proposal. Approval of each of the M&A
Amendment Proposals requires the affirmative vote of at least two-thirds of the votes cast by shareholders represented at the Meeting
who, being entitled to do so, vote in person or by proxy thereon. Approval of each of the Auditor Ratification Proposal and the Adjournment
Proposal requires the affirmative vote of a simple majority of the votes cast by shareholders represented at the Meeting who, being entitled
to do so, vote in person or by proxy thereon.

In connection with the M&A
Amendment Proposals, holders (“public shareholders”) of the Company’s Class A ordinary shares, $0.0001,
par value per share included in the units sold in the Company’s initial public offering (“IPO”) (“public shares” or “Public Shares”), may elect to redeem their